Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Invasive aspergillosis management in ICU patients

This promotional meeting is organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics.

  • Fungal Topic

Invasive aspergillosis management in ICU patients

Date: 3rd November & 5th November

Time: 12pm - 3rd November 
            6pm - 5th November

Duration: 1 Hour

Additional details: This is a live webinar. A live Q&A with Dr Silke Schelenz will be available.

Register Here

About the webinar

This webinar is a promotional meeting that will focus on:
•    Influenza-related invasive aspergillosis (IA)
•    Sharing experience of managing IA patients in ICU in the current environment
•    How to optimise critically ill patient management
•    How to use diagnostics for IA patients

About the speaker

Dr Silke Schelenz 
Consultant Microbiologist
Kings College Hospital, London,
Senior Lecturer, Imperial College

This meeting is organised & funded by Pfizer Ltd. Please note that, under the law and the ABPI Code of Practice, Pfizer may only promote its medicines and provide hospitality to members of the healthcare professions and other relevant decision makers. Therefore, no unqualified person (e.g. medical students, non-medical spouses/partners/family members) may be invited to or attend Pfizer promotional meetings.